JP2005536463A - 17α−フルオロアルキル−11β−ベンズアルドキシムステロイド、それらの製造方法、これらのステロイド類を含有する製剤及び医薬品製造のためのそれらの使用 - Google Patents

17α−フルオロアルキル−11β−ベンズアルドキシムステロイド、それらの製造方法、これらのステロイド類を含有する製剤及び医薬品製造のためのそれらの使用 Download PDF

Info

Publication number
JP2005536463A
JP2005536463A JP2004501431A JP2004501431A JP2005536463A JP 2005536463 A JP2005536463 A JP 2005536463A JP 2004501431 A JP2004501431 A JP 2004501431A JP 2004501431 A JP2004501431 A JP 2004501431A JP 2005536463 A JP2005536463 A JP 2005536463A
Authority
JP
Japan
Prior art keywords
benzaldehyde
dien
oxoestradi
oxime
pentafluoroethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004501431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005536463A5 (cg-RX-API-DMAC7.html
Inventor
リンク,スフェン
シュベルト,ゲルト
トルヌス,インゴ
カウフマン,ギュンター
エルガー,バルター
シュナイダー,ビルギット
Original Assignee
シエーリング アクチエンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10221034A external-priority patent/DE10221034A1/de
Application filed by シエーリング アクチエンゲゼルシャフト filed Critical シエーリング アクチエンゲゼルシャフト
Publication of JP2005536463A publication Critical patent/JP2005536463A/ja
Publication of JP2005536463A5 publication Critical patent/JP2005536463A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2004501431A 2002-05-03 2003-05-05 17α−フルオロアルキル−11β−ベンズアルドキシムステロイド、それらの製造方法、これらのステロイド類を含有する製剤及び医薬品製造のためのそれらの使用 Pending JP2005536463A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10221034A DE10221034A1 (de) 2002-05-03 2002-05-03 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US44940103P 2003-02-25 2003-02-25
PCT/EP2003/004686 WO2003093292A1 (de) 2002-05-03 2003-05-05 17α-FLUORALKYL-11β-BENZALDOXIM-STEROIDE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE STEROIDE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN

Publications (2)

Publication Number Publication Date
JP2005536463A true JP2005536463A (ja) 2005-12-02
JP2005536463A5 JP2005536463A5 (cg-RX-API-DMAC7.html) 2006-06-22

Family

ID=29403591

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004501431A Pending JP2005536463A (ja) 2002-05-03 2003-05-05 17α−フルオロアルキル−11β−ベンズアルドキシムステロイド、それらの製造方法、これらのステロイド類を含有する製剤及び医薬品製造のためのそれらの使用

Country Status (8)

Country Link
EP (1) EP1501859B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005536463A (cg-RX-API-DMAC7.html)
AT (1) ATE307823T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003227717A1 (cg-RX-API-DMAC7.html)
DE (1) DE50301507D1 (cg-RX-API-DMAC7.html)
DK (1) DK1501859T3 (cg-RX-API-DMAC7.html)
ES (1) ES2252670T3 (cg-RX-API-DMAC7.html)
WO (1) WO2003093292A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012533576A (ja) * 2009-07-20 2012-12-27 バイエル ファーマ アクチエンゲゼルシャフト 17−ヒドロキシ−17−ペンタフルオロエチルエストラ−4,9(10)−ジエン11−ベンジリデン誘導体、その製造方法、及び疾患治療のためのその使用

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006054535A1 (de) 2006-11-15 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Progesteronrezeptorantagonisten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE19745085A1 (de) * 1997-10-11 1999-04-15 Jenapharm Gmbh 11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012533576A (ja) * 2009-07-20 2012-12-27 バイエル ファーマ アクチエンゲゼルシャフト 17−ヒドロキシ−17−ペンタフルオロエチルエストラ−4,9(10)−ジエン11−ベンジリデン誘導体、その製造方法、及び疾患治療のためのその使用

Also Published As

Publication number Publication date
WO2003093292A1 (de) 2003-11-13
DK1501859T3 (da) 2006-03-06
EP1501859A1 (de) 2005-02-02
AU2003227717A1 (en) 2003-11-17
EP1501859B1 (de) 2005-10-26
DE50301507D1 (de) 2005-12-01
ATE307823T1 (de) 2005-11-15
ES2252670T3 (es) 2006-05-16

Similar Documents

Publication Publication Date Title
CA1327352C (en) Steroid 5-.alpha.-reductase inhibitors
RU2187510C2 (ru) Производные 16-гидрокси-11-(замещенный фенил)-эстра-4,9-диена, соединение, фармацевтическая композиция
JP3462515B2 (ja) 17−スピロフラン−3′−イリデンステロイド
FR2598421A1 (fr) Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2618783A1 (fr) Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
EP2081951A1 (en) Progesterone receptor antagonists
US6825182B2 (en) 17α-fluoroalkyl-11β-benzaldoxime steroids, process for their production, pharmaceutical preparations that contain these steroids as well as their use for the production of pharmaceutical agents
JP2717792B2 (ja) 新規な7−置換19−ノルステロイド、それらの製造法、薬剤としての使用及びそれらを含有する製薬組成物
DE3921059A1 (de) 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
CN103842370A (zh) 黄体酮拮抗剂
JPH1077292A (ja) 心臓血管系に活性のある新規の6−ヒドロキシおよび6−オキソ−アンドロスタン誘導体およびそれらを含有する製薬用組成物
JPH01156995A (ja) 新規なアンドロスタン17−カルボン酸エステル、その製法及びそれを含む薬剤
JPH09183792A (ja) ステロイド誘導体のケタールの製造方法
JP3466651B2 (ja) 17位にメチレンラクトン基を含有する新規なステロイド、それらの製造法及び中間体、それらの薬剤としての使用並びにそれらを含有する製薬組成物
JP2677626B2 (ja) 17−置換アンドロスタ−1,4−ジエン−3−オン誘導体
ES2252670T3 (es) Esteroides con fluoroalquilo en 17a y benzaldoxima en 11beta, procedimiento para su preparacion, formulaciones farmaceuticas que contienen estos esteroides, asi como su utilizacion para la produccion de medicamentos.
JPS62158300A (ja) 10β−アルキニルエストレン誘導体およびそれらの製造法
JPS6118798A (ja) 新規の11β位置換ステロイド誘導体、それらの製造方法及びそれらの薬剤としての使用
KR20030010575A (ko) 담즙산과의 4-벤질아미노퀴놀린 결합체, 이의 이종동족체, 이의 제조방법, 이들 화합물을 함유하는 약제 및이의 용도
JPH0155280B2 (cg-RX-API-DMAC7.html)
EP0567472A1 (de) D-homo-(16-en)-11 beta-aryl-4-estrene,verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel.
US5438134A (en) Process for the production of unsaturated 17 α-cyanomethyl-17 β-h
EP1237903A1 (de) 11-beta-phenylestradien-derivate mit fluoralkylgruppen in der aromatischen seitenkette, deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
JPS6321680B2 (cg-RX-API-DMAC7.html)
JP2834721B2 (ja) 17α−シアノメチルエストラ−4,9−ジエン誘導体、その製造方法および該化合物を含有する医薬品

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060502

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060502

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091222

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100518